2023
Clear cell chondrosarcoma: a review of clinicopathologic characteristics, differential diagnoses, and patient management
Alexiev B, Vormittag-Nocito E, Peabody T, Samet J, Laskin W. Clear cell chondrosarcoma: a review of clinicopathologic characteristics, differential diagnoses, and patient management. Human Pathology 2023, 139: 126-134. PMID: 37805864, DOI: 10.1016/j.humpath.2023.06.004.Peer-Reviewed Original ResearchConceptsClear cell chondrosarcomaDiagnosis of clear cell chondrosarcomaPrimary bone tumorsDiagnostic accuracy of core needle biopsyAccuracy of core needle biopsyBone tumorsRarest primary bone tumorsLocal recurrence rateAbundant clear cytoplasmCore needle biopsyRate of recurrenceYounger patient ageLow-grade chondrosarcomaSkeletally immature patientsMalignant cartilaginous neoplasmsDecades of lifeEpiphysis of long bonesLow diagnostic accuracyOperative resectionIncomplete excisionNeedle biopsyHistopathological diagnosisPatient ageRecurrence rateClinicopathological characteristics
2000
The “neurothekeoma”: Immunohistochemical analysis distinguishes the true nerve sheath myxoma from its mimics
Laskin W, Fetsch J, Miettinen M. The “neurothekeoma”: Immunohistochemical analysis distinguishes the true nerve sheath myxoma from its mimics. Human Pathology 2000, 31: 1230-1241. PMID: 11070116, DOI: 10.1053/hupa.2000.18474.Peer-Reviewed Original ResearchConceptsGlial fibrillary acidic proteinNerve sheath myxomaSpindled cellsPeak incidenceFemale ratioLow-affinity nerve growth factor receptorDense collagenAlpha-smooth muscle actinAnti-neurofilament proteinSoft Tissue RegistryNerve sheath tumorsNerve growth factor receptorDecades of lifeEpithelial membrane antigenFibrillary acidic proteinCollagen type IV expressionGrowth factor receptorSheath tumorsAnatomic distributionLeu-7Consistent immunoreactivityMyxoid variantTissue RegistryImmunohistochemical analysisEpithelioid cells